Research Article
NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs
| RNA target | Product company | Primer sequences | Amplicon length (base pairs) | Function related to oxidative stress (references) |
| mRNA NRF2 | Sigma | Forward: 5-CAATGAGGTTTCTTCGGCTACG-3 Reverse: 5-AAGACTGGGCTCTCGATGTG-3 | 72 | Major redox response regulator [1] | mRNA NRF1 | Sigma | Forward: 5-ATGGAAATGCAGGCCATGGAAG-3 Reverse: 5-GAGGGGCACTGTACAGGATTT-3 | 61 | Redox response regulator [5] | GAPDH | Sigma | Forward: 5-TGGAAGGACTCATGACCACA-3 Reverse: 5-CCATCACGCCACAGTTT-3 | | — | miR-23B-3p | Qiagen | 5AUCACAUUGCCAGGGAUUACC | | Predicted NRF2 inhibition [40] | miR-93-5p | Qiagen | 5CAAAGUGCUGUUCGUGCAGGUAG | | Predicted NRF2 inhibition [40] | miR-144-3p | Qiagen | 5UACAGUAUAGAUGAUGUACU | | Predicted NRF2 inhibition [8, 40, 52] | miR-212-3p | Qiagen | 5UAACAGUCUCCAGUCACGGCC | | NRF1 and NRF2 inhibition, interaction with Mn-SOD | miR-340-3p | Qiagen | 5UCCGUCUCAGUUACUUUAUAGC | | MAPK signalling, predicted NRF1 inhibition [40] | miR-383-5p | Qiagen | 5AGAUCAGAAGGUGAUUGUGGCU | | No predicted inhibition of NRF1/NRF2 | miR-510-5p | Qiagen | 5UACUCAGGAGAGUGGCAAUCAC | | No predicted inhibition of NRF1/NRF2 | RNU-6B | Qiagen | (Not reported, product no. 218300 cat. no. MS00014000) | | — |
|
|